E-sellers of compounded weight-loss drugs fail to reveal risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks associated with these medicines, according to a research letter published on Friday.
Novo Nordisk high dose weight loss data ‘a double edged sword,’ says BofA
After Novo Nordisk (NVO) reported results from its Phase 3b STEP UP trial, which showed that adults with obesity achieved a 20.7% weight loss
Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli Lilly's rival drug Zepbound,
Wegovy at Higher Dose Achieves Greater Weight Loss in Trial
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side effects.
Novo Nordisk says higher Wegovy dose caused over 20% weight loss in late-stage trial
Novo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as Wegovy led to 20.7% weight loss over 72 weeks compared to 17.5% weight loss achieved by regular semaglutide in a late-stage trial.
Novo Nordisk says its high-dose semaglutide trial shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight patients lower their weight by 20.7%. The trial was testing a 7.2 milligram dose of the drug,
Mounjaro vs. Ozempic: Which One Is Best for Me to Try for Weight Loss in 2025?
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
CNET on MSN2d
For Weight Loss, Experts Recommend These 3 Workouts
If you're looking to lose weight and up your fitness game at the same time, these are the best weight-loss workouts that ...
Medical News Today4d
As little as 30 minutes of aerobic exercise per week may aid weight loss, reduce fat
A study finds that people who engage in just 30 minutes of exercise per week see modest improvements in body weight and body ...
The 10 Best Anti-Inflammatory Foods for Weight Loss, Ranked
Fight inflammation and shed pounds with these top 10 anti-inflammatory foods ranked by their weight-loss benefits.
Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
CNET on MSN7d
Start Weight Loss Fresh in the New Year by Leaving These 6 Habits Behind
A diet rich in fruit, vegetables, healthy fats, lean proteins and some whole grains will serve you best in terms of ...
The Best High-Protein Breakfast for Weight Loss, Recommended by Dietitians
Eggs are probably top of mind when you think about adding more protein to your breakfast, but don’t forget about plant-based ...
Medicare to negotiate prices for weight loss drugs: What to know
The Biden administration says it will be including weight loss drugs like Ozempic and Wegovy in the next round of drug ...
Outgoing FDA Chief Flags Online Weight Loss Drug Dangers
Novo Nordisk's and Eli Lilly's weight loss drugs can cost over $1,000 for a month's supply, while compounded versions ...